Homology Modeling, Docking Studies and Molecular Dynamic Simulations Using Graphical Processing Unit Architecture to Probe the Type‐11 Phosphodiesterase Catalytic Site: A Computational Approach for the Rational Design of Selective Inhibitors. (26th August 2013)
- Record Type:
- Journal Article
- Title:
- Homology Modeling, Docking Studies and Molecular Dynamic Simulations Using Graphical Processing Unit Architecture to Probe the Type‐11 Phosphodiesterase Catalytic Site: A Computational Approach for the Rational Design of Selective Inhibitors. (26th August 2013)
- Main Title:
- Homology Modeling, Docking Studies and Molecular Dynamic Simulations Using Graphical Processing Unit Architecture to Probe the Type‐11 Phosphodiesterase Catalytic Site: A Computational Approach for the Rational Design of Selective Inhibitors
- Authors:
- Cichero, Elena
D'Ursi, Pasqualina
Moscatelli, Marco
Bruno, Olga
Orro, Alessandro
Rotolo, Chiara
Milanesi, Luciano
Fossa, Paola - Abstract:
- <abstract abstract-type="main" id="cbdd12193-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Phosphodiesterase 11 (PDE11) is the latest isoform of the PDEs family to be identified, acting on both cyclic adenosine monophosphate and cyclic guanosine monophosphate. The initial reports of PDE11 found evidence for PDE11 expression in skeletal muscle, prostate, testis, and salivary glands; however, the tissue distribution of PDE11 still remains a topic of active study and some controversy. Given the sequence similarity between PDE11 and PDE5, several PDE5 inhibitors have been shown to cross‐react with PDE11. Accordingly, many non‐selective inhibitors, such as IBMX, zaprinast, sildenafil, and dipyridamole, have been documented to inhibit PDE11. Only recently, a series of dihydrothieno[3, 2‐<italic>d</italic>]pyrimidin‐4(3<italic>H</italic>)‐one derivatives proved to be selective toward the PDE11 isoform. In the absence of experimental data about PDE11 X‐ray structures, we found interesting to gain a better understanding of the enzyme–inhibitor interactions using <italic>in silico</italic> simulations. In this work, we describe a computational approach based on homology modeling, docking, and molecular dynamics simulation to derive a predictive 3D model of PDE11. Using a Graphical Processing Unit architecture, it is possible to perform long simulations, find stable interactions involved in the complex, and finally to suggest guideline for the identification and<abstract abstract-type="main" id="cbdd12193-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Phosphodiesterase 11 (PDE11) is the latest isoform of the PDEs family to be identified, acting on both cyclic adenosine monophosphate and cyclic guanosine monophosphate. The initial reports of PDE11 found evidence for PDE11 expression in skeletal muscle, prostate, testis, and salivary glands; however, the tissue distribution of PDE11 still remains a topic of active study and some controversy. Given the sequence similarity between PDE11 and PDE5, several PDE5 inhibitors have been shown to cross‐react with PDE11. Accordingly, many non‐selective inhibitors, such as IBMX, zaprinast, sildenafil, and dipyridamole, have been documented to inhibit PDE11. Only recently, a series of dihydrothieno[3, 2‐<italic>d</italic>]pyrimidin‐4(3<italic>H</italic>)‐one derivatives proved to be selective toward the PDE11 isoform. In the absence of experimental data about PDE11 X‐ray structures, we found interesting to gain a better understanding of the enzyme–inhibitor interactions using <italic>in silico</italic> simulations. In this work, we describe a computational approach based on homology modeling, docking, and molecular dynamics simulation to derive a predictive 3D model of PDE11. Using a Graphical Processing Unit architecture, it is possible to perform long simulations, find stable interactions involved in the complex, and finally to suggest guideline for the identification and synthesis of potent and selective inhibitors.</p> </abstract> … (more)
- Is Part Of:
- Chemical biology & drug design. Volume 82:Number 6(2013:Dec.)
- Journal:
- Chemical biology & drug design
- Issue:
- Volume 82:Number 6(2013:Dec.)
- Issue Display:
- Volume 82, Issue 6 (2013)
- Year:
- 2013
- Volume:
- 82
- Issue:
- 6
- Issue Sort Value:
- 2013-0082-0006-0000
- Page Start:
- 718
- Page End:
- 731
- Publication Date:
- 2013-08-26
- Subjects:
- Drugs -- Design -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
615.19005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01253034-000000000-00000 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1747-0285 ↗
http://www.blackwell-synergy.com/loi/jpp ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cbdd.12193 ↗
- Languages:
- English
- ISSNs:
- 1747-0277
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3139.120000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3191.xml